2011

Global Bioenergies deploys its R&D platform

Global Bioenergies S.A. (FR0011052257 – NYSE Alternext : ALGBE), an industrial biology company developing sustainable routes to light olefins, today announces the extension of its R&D platform.

[+] Previous page

Agenda

21 - 23 May 2012
World Stem Cells & Regenerative Medicine Congress: Victoria Park Plaza, London, UK

11 - 13 September 2012
World Biosimilars Congress: Jumeirah Carlton Tower, London, UK

May 31- June 1, 2012
Euro Medtech 2012: Grenoble

September 5-8, 2012
WMIC 2012 - Wolrd Molecular Imaging Congress: Dublin, Ireland

[+] Consult the agenda

In order to receive
Genopole^® press releases^®,
please provide your coordinates
to Press Service